Q4 2013 13F Holders as of 31 Dec 2013
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
19,667,509
-
Total 13F shares
-
20,499,438
-
Share change
-
+121,950
-
Total reported value
-
$1,080,081,649
-
Put/Call ratio
-
27%
-
Price per share
-
$52.60
-
Number of holders
-
160
-
Value change
-
+$6,766,790
-
Number of buys
-
2
-
Number of sells
-
4
Institutional Holders of LIGAND PHARMACEUTICALS INC - Common Stock (LGND) as of Q4 2013
As of 31 Dec 2013,
LIGAND PHARMACEUTICALS INC - Common Stock (LGND) was held by
160 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
20,499,438 shares.
The largest 10 holders included
BVF INC/IL, FMR LLC, BlackRock Fund Advisors, RS INVESTMENT MANAGEMENT CO LLC, Knott David M, BLAIR WILLIAM & CO/IL, VANGUARD GROUP INC, State Street Corp, CARDINAL CAPITAL MANAGEMENT LLC /CT, and BlackRock Institutional Trust Company, N.A..
This page lists
160
institutional shareholders reporting positions in this security
for the Q4 2013 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.